Glasgow-Blatchford Score Calculator — Upper GI Bleeding Risk Assessment
The Glasgow-Blatchford Score (GBS) is a validated pre-endoscopy risk stratification tool for patients presenting with upper gastrointestinal bleeding. It identifies patients at low risk (<0.5% needing intervention) who may be suitable for outpatient management without urgent endoscopy.
About
The Glasgow-Blatchford Score was developed by Blatchford et al. in 2000 as a pre-endoscopy risk assessment tool to predict the need for intervention (blood transfusion, endoscopic therapy, or surgery) in patients with acute upper GI bleeding. The score incorporates eight clinical and laboratory parameters: blood urea nitrogen (BUN), hemoglobin, systolic blood pressure, heart rate, presence of melena, syncope, hepatic disease, and heart failure. A score of 0 identifies patients at very low risk (<0.5%) who can be safely managed as outpatients. The score ranges from 0-23, with higher scores indicating greater risk of needing intervention and worse outcomes.
Formula
GBS = BUN (0-6) + Hemoglobin (0-6) + Systolic BP (0-3) + Pulse (0-1) + Melena (0-1) + Syncope (0-2) + Hepatic Disease (0-2) + Heart Failure (0-2)
The Glasgow-Blatchford Score is calculated by summing points from eight clinical and laboratory parameters. BUN (mg/dL): <18.2 = 0, 18.2-22.3 = 2, 22.4-27.9 = 3, 28-69.9 = 4, ≥70 = 6. Hemoglobin (g/dL) — Male: ≥13 = 0, 12-12.9 = 1, 10-11.9 = 3, <10 = 6; Female: ≥12 = 0, 10-11.9 = 1, <10 = 6. Systolic BP (mmHg): ≥110 = 0, 100-109 = 1, 90-99 = 2, <90 = 3. Pulse (bpm): <100 = 0, ≥100 = 1. Melena: absent = 0, present = 1. Syncope: absent = 0, present = 2. Hepatic disease: absent = 0, present = 2. Heart failure: absent = 0, present = 2. Total score ranges from 0 to 23. A score of 0 identifies patients at very low risk (<0.5% need for intervention) who may be suitable for discharge. Scores ≥6 indicate high risk of needing endoscopic intervention. The GBS has been shown to be superior to clinical judgment alone and the Rockall score in predicting the need for intervention in upper GI bleeding.
Score Interpretation
The Glasgow-Blatchford Score (GBS) is the most validated pre-endoscopy risk score for upper GI bleeding. Its primary clinical utility is identifying patients at very low risk (score 0) who can be safely managed as outpatients, potentially reducing unnecessary hospital admissions. The GBS has been shown to be superior to clinical judgment alone and the Rockall score in predicting the need for intervention. In patients with a GBS of 0, the risk of needing endoscopic intervention is <0.5%, and none require blood transfusion. The score also predicts 30-day mortality, rebleeding risk, and length of hospital stay. Key limitations: the score requires laboratory values (BUN, hemoglobin), which may not be immediately available in all settings; it does not incorporate age or comorbid illness beyond hepatic disease and heart failure; and it was validated primarily in ED populations with upper GI bleeding. Modified versions include the AIMS65 score and the pre-endoscopy Rockall score.
Low Risk — 0–0
Score 0 — <0.5% risk of needing intervention. Suitable for outpatient management/discharge.
Management: May be suitable for outpatient management. No urgent endoscopic intervention required. Consider early discharge with clear instructions for return if symptoms worsen.
Moderate Risk — 1–5
Score 1-5 — Low-intermediate risk. Further assessment and monitoring needed.
Management: Admit for observation. Consider endoscopy within 24 hours. Start IV PPI and monitor hemoglobin. Type and crossmatch.
High Risk — 6–11
Score 6-11 — High risk of needing endoscopic intervention.
Management: Urgent endoscopy recommended (within 12-24 hours). IV PPI infusion. Type and crossmatch. ICU or monitored bed recommended.
Very High Risk — 12–23
Score 12-23 — Very high risk. Urgent endoscopy and intervention likely needed.
Management: Emergency endoscopy. ICU admission strongly recommended. IV PPI bolus + infusion. Blood transfusion as needed. Surgical or interventional radiology consult.
Reference Ranges
| Population | Normal Range | Notes |
|---|---|---|
| Adults presenting with upper GI bleeding | 0-23 points | Score 0: Very low risk (<0.5% need intervention). Score ≥6: High risk. Higher scores predict need for endoscopic intervention, transfusion, and mortality. |
Dr. Mahmoud El-Sayed
Dr. Mahmoud is an endocrinology consultant with expertise in metabolic and gastrointestinal disorders.
View medical review board & editorial policy →Example Calculation
A 62-year-old man presents to the ED with melena and a syncopal episode. He has a history of cirrhosis (hepatic disease). Vital signs: BP 105/70 mmHg, HR 108 bpm. Labs: BUN 35 mg/dL, Hemoglobin 11.2 g/dL. BUN 35 → 4 points (28-69.9). Hemoglobin 11.2 (male, 10-11.9) → 3 points. SBP 105 → 1 point (100-109). HR 108 → 1 point (≥100). Melena present → 1 point. Syncope present → 2 points. Hepatic disease present → 2 points. Heart failure absent → 0 points. Total GBS = 4 + 3 + 1 + 1 + 1 + 2 + 2 + 0 = 14 points (Very High Risk). This patient requires emergency endoscopy, ICU admission, IV PPI, and blood transfusion. Surgical consult should be obtained.
Related Conditions
Related Medications
Common Mistakes
Using GBS to predict mortality rather than need for intervention
GBS was designed and validated to predict the need for clinical intervention (blood transfusion, endoscopic therapy, or surgery), not specifically mortality. Consider the Rockall or AIMS65 scores for mortality prediction.
Interpreting a moderate score (1-5) as low risk without clinical correlation
Only a GBS of 0 reliably identifies patients suitable for discharge. Scores 1-5 require clinical assessment and may still need admission, especially in elderly patients or those with significant comorbidities.
Frequently Asked Questions
What is the difference between the Glasgow-Blatchford Score and the Rockall score?
Can a patient with GBS of 0 really be discharged from the ED?
Does the GBS apply to both hematemesis and melena presentations?
References
- Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet. 2000;356(9238):1318-1321. PubMed
- Stanley AJ, Ashley D, Dalton HR, et al. Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation. Lancet. 2009;373(9657):42-47. PubMed
- Laursen SB, Dalton HR, Murray IA, et al. Performance of new thresholds of the Glasgow Blatchford score in managing patients with upper gastrointestinal bleeding. Clin Gastroenterol Hepatol. 2015;13(1):115-121. PubMed